Isatuximab as a Treatment Option for MM

Paul Richardson, MD, Clinical Program Leader, Director of Clinical Research, Jerome Lipper Multiple Myeloma, Institute Physician, Harvard Medical School considers whether isatuximab can remain a treat... Author: obr Added: 07/01/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts